Latest filing published 13 Aug 2021 for Rossari Biotech Limited, €20k.
Filing timeline
BuySaleManasi Nisal: trading record in brief
Manasi Nisal, listed as chief executive, appears in our data through filings on Rossari Biotech Limited shares, published by SEBI (PIT + SAST). Between 17 July 2021 and 11 August 2021, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 13 August 2021 with a transaction (€20k) in Rossari Biotech Limited. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Manasi Nisal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,300 shares@ ₹1,350.050.0001% mcap15.6% of flowEquity SharesSEBI:bf395dce041eca2665c9e7b308203e9cb549bed6
- 3,000 shares@ ₹1,289.180.0002% mcap33.9% of flowEquity SharesSEBI:0c0b4c77e1cda6ffe357278ede453362255ff4a4
- 1,700 shares@ ₹1,320.000.0001% mcap19.7% of flowEquity SharesSEBI:0c3e43b3d807b97631c55b6dca8316f8bacd0e41
- 3,000 shares@ ₹1,167.450.0002% mcap30.8% of flowEquity SharesSEBI:5c56954dfa534b5de3c87e3d4082c40900ed44eeCanonical exit: 15 Oct 2021 (T+90)
4 of 4 declarations